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Salmonella colonization of food animals is a concern for animal health and public health 
as a food safety risk. Various obstacles impede the effort to reduce asymptomatic 
Salmonella carriage in food animals, including the existence of numerous serovars and 
the ubiquitous nature of Salmonella. To develop an intervention strategy that is non-spe-
cific yet effective against diverse Salmonella serovars, we explored the prophylactic use 
of a cytokine to decrease Salmonella in swine by boosting the host’s innate immune sys-
tem. Granulocyte-colony stimulating factor (G-CSF) is the major cytokine regulating the 
production, differentiation, function, and survival of neutrophils. Neutrophils play a critical 
role in the response to Salmonella; therefore, we evaluated the vectored-delivery of por-
cine G-CSF as a prophylactic to reduce Salmonella in pigs. Crossbred pigs, 5 weeks of 
age, were intramuscularly injected with a replication-defective human adenovirus (Ad5) 
engineered to express porcine G-CSF (Ad5-G-CSF, n = 9). Control pigs received the 
same Ad5 vector lacking the gene encoding G-CSF (Ad5-empty, n = 7). Four days later, 
all pigs (n = 16) were intranasally inoculated with 1 × 107 colony forming unit (CFU) of 
Salmonella enterica serovar Typhimurium UK1. At 2 and 3  days post-challenge with 
Salmonella, Ad5-G-CSF-treated pigs shed significantly less Salmonella (~103  CFU/g) 
in their feces than Ad5-empty-treated pigs (~104–105 CFU/g; P < 0.05). A significant 
4-log reduction in tonsil colonization was also observed in the Ad5-G-CSF-treated 
pigs at 7 days post-challenge (P < 0.05). In the gastrointestinal tract, the Peyer’s patch 
region of the ileum exhibited a significant 0.5-log reduction in colonization in the Ad5-
G-CSF-treated pigs (P <  0.05). The microbiota of all challenged pigs was assessed 
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inTrODUcTiOn
Asymptomatically colonized food animals are a major reservoir 
of the human foodborne pathogen Salmonella (1–3). Intervention 
strategies are needed to not only decrease the overall prevalence 
of Salmonella in food animals but also reduce an animal’s sus-
ceptibility to Salmonella during times of production stress, such 
as farrowing, weaning, mixing, and transportation. Controlling 
Salmonella is challenging due to the broad host range, ubiquitous 
distribution, and number of Salmonella serovars (>2,500). To 
overcome the complexity of Salmonella, management strategies 
that target innate immune mechanisms warrant exploration 
to control the commensal-like state of this human foodborne 
pathogen in the gastrointestinal tract of animals contributing to 
our food (animal) supply.
An animal’s innate immune system offers multiple pathways 
that can be modulated to fight disease-causing agents without 
activation of the adaptive immune system, which is the primary 
target of vaccination strategies. Instead, bolstering an innate 
immune response during stressful events in animal production or 
periods of immune dysfunction could reduce pathogen recrudes-
cence and infection susceptibility. One possible intervention to 
address this vulnerability is the prophylactic use of biotherapeutic 
proteins, such as cytokines [reviewed in Ref. (4)]. Granulocyte-
colony stimulating factor (G-CSF) is a cytokine involved in 
the production, differentiation, and function of granulocytes 
(especially neutrophils) from bone marrow (5–7). Neutrophils 
are phagocytic cells of the innate immune system, and their 
killing mechanism provides a critical first line of defense against 
bacterial and viral infections (8). Recombinant human G-CSF 
(Neulasta, Amgen Inc.) is FDA-approved for use in humans 
to decrease the incidence of infection in neutropenic patients 
receiving myelosuppressive anti-cancer drugs (9). Recombinant 
bovine G-CSF (Imrestor, Elanco) has also been approved by the 
FDA for use in dairy cattle to restore neutrophil function and 
neutrophil numbers during periparturient immune suppression 
(10–13). Previous work by our group established that the delivery 
of a replication-defective human adenovirus 5 encoding porcine 
G-CSF increased the number of functional neutrophils in circula-
tion (14), thus demonstrating the potential for modulating the 
swine immune system by targeting the G-CSF pathway.
Rapid neutrophil influx into the intestines is the hallmark of 
a Salmonella infection (15, 16). In our previous work, cytokines 
involved in neutrophil production and recruitment were 
upregulated in swine following Salmonella challenge (17, 18). 
Furthermore, van Diemen et al. demonstrated higher numbers 
of circulating neutrophils with greater polymorphonuclear neu-
trophil (PMN) function in pigs bred for resistance to Salmonella 
enterica serovar Choleraesuis (19). Thus, we hypothesized that 
elevating the abundance of circulating neutrophils in pigs prior 
to Salmonella exposure may assist in controlling Salmonella 
colonization and shedding. The results demonstrate the beneficial 
effects of Ad5-G-CSF-induced neutrophilia on the reduction of 
S. enterica serovar Typhimurium (S. Typhimurium) colonization 
and shedding in swine, as well as decreased Salmonella-induced 
disturbance of the gastrointestinal microbiota, suggesting pro-
phylactic use of porcine Ad5-G-CSF may serve as a biotherapeutic 
approach to reduce Salmonella in pigs.
MaTerials anD MeThODs
swine experiment
Sixteen crossbred, conventionally reared piglets from three 
Salmonella-fecal-negative sows were weaned at 12 days of age and 
shipped to the National Animal Disease Center, Ames, IA, USA. 
Siblings from each litter were divided and raised in two isolation 
rooms. Piglets tested fecal-negative for Salmonella spp. twice over a 
2-week period using bacteriological culture with selective enrich-
ment (20). At 5 weeks of age, piglets received an intramuscular 
injection of 1010 TCID50/pig of a replication-defective human 
adenovirus (Ad5) engineered to express porcine G-CSF (Ad5-G-
CSF, n = 9) (14). As previously described, Ad5-G-CSF was derived 
by directionally cloning G-CSF cDNA into the AdEasyTM XL 
System (Stratagene, La Jolla, CA, USA) and propagated in spe-
cialized AD-HEK-293 cells. Control pigs received the same Ad5 
vector lacking the gene encoding G-CSF (Ad5-empty, n =  7). 
Four days later, all pigs (n = 16) were intranasally inoculated with 
1 × 107 colony forming unit (CFU) of a nalidixic acid-resistant 
derivative of S. enterica serovar Typhimurium UK1 (21) that had 
been passaged in swine and isolated from the ileocecal lymph 
node of a pig (strain name: SB 377). Fecal samples were collected 
at 0, 1, 2, 3, and 7 days post-inoculation (d.p.i.) for microbiota 
analysis as well as quantitative and qualitative Salmonella culture 
analyses (see below). Blood samples were collected from the 
jugular vein at −4, −2, 0, 1, 2, 3, and 7 d.p.i. for enumeration of 
circulating blood cells by flow cytometry (see below). At 7 d.p.i., 
all pigs were euthanized and necropsied to obtain tissue samples 
from the tonsil and the intestinal tract (ileal Peyer’s patches, 
ileocecal lymph nodes, and cecum) for quantitative and qualita-
tive Salmonella culture analysis (see below). Procedures involving 
by sequencing and analyzing the V1–V3 region of the 16S rRNA gene from fecal DNA 
samples. The microbial community structure of Salmonella-challenged pigs was less 
disturbed post-challenge in the Ad5-G-CSF-treated pigs than the Ad5-empty-treated 
pigs. This suggests that Ad5-G-CSF administration mitigated changes in the microbial 
community structure caused by Salmonella challenge. Collectively, these data suggest 
that delivery of a targeted immunostimulant to enhance neutropoiesis may be a strategy 
to reduce Salmonella colonization, potentially during periods of immunological stress.
Keywords: Salmonella, granulocyte-colony stimulating factor, swine, immune stimulation, alternatives to 
antibiotics
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animals followed humane protocols as approved by the USDA, 
ARS, NADC Animal Care and Use Committee in strict accord-
ance with the recommendations in the Guide for the Care, and 
Use of Laboratory Animals of the National Institutes of Health.
Bacteriology
For quantitative bacteriology, 1 g of pig feces was combined with 
5 ml PBS, vortexed, and 0.1 ml directly plated to XLT-4 medium 
(Beckton, Dickinson and Co., Sparks, MD, USA) containing 
30 μg/ml of nalidixic acid. For tissue samples, 1 g of each tissue 
was combined with 2 ml of PBS in a whirlpak bag, pounded with 
a mallet, and homogenized in a Stomacher (Seward, Westbury, 
NY, USA) for 1 min. One hundred microliters of the resulting 
solution was aliquoted onto XLT-4 medium containing nalidixic 
acid. One hundred microliters of a 10-fold dilution of each fecal 
and tissue sample was also plated, and additional dilutions were 
performed when CFU reached >300/plate. Following 48  h of 
incubation at 37°C, black colonies were enumerated and a sin-
gle colony from each plate was confirmed to be Salmonella by 
serogroup antiserum agglutination (Beckton, Dickinson and Co., 
Sparks, MD, USA). The total number of CFU for each quantita-
tive tissue or fecal sample was calculated per gram of sample by 
obtaining the number of Salmonella per plate and multiplying by 
the dilution factor.
Qualitative bacteriology of Salmonella was performed as fol-
lows: 1  g (fecal) or 0.1  ml (homogenized tissue) samples were 
inoculated in 10 ml tetrathionate broth (TET; VWR, Rutherford, 
NJ, USA) for 48 h of growth at 37°C. Following incubation, 0.1 ml 
of each culture was transferred to 10 ml Rappaport–Vassiliadis 
medium (RV; Difco) and incubated at 37°C for 18–20 h. Cultures 
were streaked on XLT-4 medium containing nalidixic acid. 
Colonies suspicious for Salmonella were confirmed by serogroup 
antiserum agglutination.
Statistical analysis for Salmonella shedding in feces (CFU/g) 
was Log10-transformed and analyzed using a mixed linear 
model for repeated measures (Proc Mixed in SAS for Windows, 
version 9.2; SAS Institute Inc., Cary, NC, USA). Covariance 
structures within pigs across time were tested and modeled 
using the REPEATED statement to determine the optimal 
covariance structure. Linear combinations of the least-squares 
mean estimates were used in a priori contrasts after testing for 
a significant (P  <  0.05) treatment group effect. Comparisons 
were made between each group at each time point, using a 5% 
level of significance (P <  0.05) to assess statistical differences. 
The endpoint data for bacterial colonization (CFU/g) of tissues 
collected at necropsy were Log10-transformed and analyzed by 
analysis of variance using a general linear model for unbalanced 
data. A  5% level of significance (P <  0.05) was used to assess 
statistical differences.
Whole Blood cell Differential
White blood cell counts were performed via flow cytometry 
as previously described (14). Briefly, a 50-μl aliquot of anti-
coagulated (EDTA) whole blood was added to a tube containing 
monoclonal antibody to porcine granulocytes (6D10, Serotech, 
USA) with appropriate secondary fluorochrome-labeled anti-
body. After a 20-min incubation, cells were fixed and red blood 
cells lysed with the addition of 1 ml FACS lyse (BD Biosciences, 
USA). Microbeads (Spherotech, USA) were added to the tube 
immediately prior to data acquisition on a flow cytometer (BD 
LSR II, Becton Dickinson, USA). A gate was drawn around the 
beads and events were collected on each parameter (neutrophil 
gate was based on forward and side scatter properties and anti-
body labeling) until the bead event number was 500. A ratio of 
total counts to bead counts was used to determine the number 
of neutrophils per microliter of blood. Calculation of statistical 
significance of neutrophils per microliter of blood by treatment 
group was performed using a one-way ANOVA with a Dunnett’s 
Multiple Comparison Test. A 5% level of significance (P < 0.05) 
was used to assess statistical differences.
16s rrna gene sequencing and analysis
Amplicon libraries of the 16S rRNA gene were generated and 
sequenced according to Kozich et al. (22), with our primers and 
procedures described previously (23). Briefly, PCRs contained 
the following: 17 μl AccuPrime Pfx SuperMix (Life Technologies, 
Grand Island, NY, USA), 5.0 μM each of the primers i5 + V3 and 
i7 + V1, and 25 ng of fecal DNA. The following PCR conditions 
were used: 2 min at 95°C, 22 cycles of (20 s at 95°C, 15 s at 55°C, 
5 min at 72°C), 72°C for 10 min. Libraries were normalized using 
the SequalPrep Normalization Plate Kit (LifeTechnologies) and 
quantified using both Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA) and Kapa SYBR Fast qPCR (Kapa Biosystems, 
Wilmington, MA, USA). Normalized pools were sequenced using 
version 3 (300 × 2) chemistry on the MiSeq instrument (Illumina, 
San Diego, CA, USA) according to manufacturer’s instructions.
Contig assembly, sequence alignment, chimera removal, and 
non-bacterial sequence removal were performed in the program 
mothur (version 1.33.3) (24). Sequences that only occurred once 
or twice across all samples were removed as potentially spurious. 
Sequences were rarified to 3,000 sequences, clustered into opera-
tional taxonomic units (OTUs) at 97% similarity, and analyzed 
for community metrics, including richness (25), evenness, and 
diversity. Analysis of similarity (ANOSIM) and non-metric 
multidimensional scaling (NMDS) analyses were conducted in 
PAST (26). Additionally, the OTUs were assigned to bacterial 
taxonomy using mothur’s implementation of the SILVA database 
(27). One sample from a pig in the Ad5-G-CSF group at day 7 
yielded insufficient sequences to be analyzed. The 16S rRNA gene 
sequences associated with this study were deposited in Genbank 
under Bioproject PRJNA339155.
resUlTs
Both Salmonella Typhimurium challenge 
and Porcine ad5-g-csF administration 
increased circulating neutrophils in Pigs
The effects of Ad5-G-CSF administration and S. Typhimurium 
challenge on circulating neutrophils were determined by enumer-
ating neutrophils in the blood at various days after Ad5-G-CSF 
administration and S. Typhimurium challenge. S. Typhimurium 
challenge alone induced a significant approximately threefold 
increase in circulating neutrophil counts, as values post-challenge 
were greater when compared to values on the day of challenge 
FigUre 2 | Fecal shedding from Salmonella-challenged pigs, with or 
without prior ad5-g-csF administration. On day 4 following Ad5-G-CSF 
or Ad5-empty administration, all 16 pigs were challenged with 1 × 107 CFU 
of S. Typhimurium UK1. Salmonella fecal shedding was monitored via 
bacteriological analysis of fecal samples collected at 1, 2, 3, and 7 d.p.i. *At 
each timepoint, significant difference (P < 0.05) in Salmonella CFU/g feces 
comparing pigs administered Ad5-G-CSF versus Ad5-empty.
FigUre 1 | The number of circulating neutrophils following 
S. Typhimurium challenge and ad5-g-csF administration. Blood 
samples were collected at the noted day relative to Salmonella challenge for 
neutrophil enumeration by flow cytometry as described in Section “Materials 
and Methods.” Data are reported as the mean + SEM. (a) Pigs were 
intranasally challenged with 1 × 107 CFU of virulent S. Typhimurium UK1 
strain (n = 7). Significant difference (P < 0.05) in circulating neutrophils 
relative to day 0 (*). (B) Pigs received a single intramuscular injection of 
Ad5-G-CSF followed by S. Typhimurium challenge with 1 × 107 CFU of S. 
Typhimurium UK1 (n = 9). Significant difference (P < 0.05) in circulating 
neutrophils relative to day −4 (*) or day 0 (#).
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(day 0) (Figure 1A). Circulating neutrophils were also enumer-
ated in pigs that were intramuscularly injected with 1010 TCID50 
Ad5-G-CSF prior to Salmonella exposure. As expected on the 
day of S. Typhimurium challenge (day 0), which was 4 days after 
Ad5-G-CSF administration, a significant neutrophilia occurred 
compared to pre-Ad5-G-CSF numbers (day −4, Figure  1B) 
or compared to Ad5-empty-treated controls on day 0 (day 0, 
Figure 1A). Following Salmonella challenge of the Ad5-G-CSF 
group, an additional significant increase in circulating neutro-
phils was observed at 3 and 7 d.p.i. compared to day 0 (day of 
Salmonella challenge). Collectively, Ad5-G-CSF administration 
induced a significant and sustained ~10-fold increase in the 
number of circulating neutrophils, and Salmonella challenge also 
induced significant increases in circulating neutrophils.
ad5-g-csF Treatment reduced Salmonella 
Fecal shedding and Tissue colonization
Salmonella shedding and tissue colonization were com-
pared between Ad5-G-CSF and Ad5-empty-treated pigs. 
Ad5-G-CSF-treated pigs shed significantly less Salmonella 
(103 CFU/g feces) when compared to the Ad5-empy-treated pigs 
at 2 and 3 d.p.i. (104–5 CFU/g feces) (Figure 2). This 1- to 2-log 
difference between the treatment groups dissipated by 7 d.p.i. 
as Salmonella shedding in the feces of Ad5-empty-treated pigs 
declined to the level of the Ad5-G-CSF-treated pigs. Typical for 
swine, a transient fever was observed in the S. Typhimurium-
challenged pigs, peaking at 2 days post-challenge; no significant 
difference was observed in the elevated body temperatures 
between treatment groups (data not shown). Gastrointestinal 
tissues (ileocecal lymph nodes, Peyer’s patch region of the 
ileum, and cecum) were analyzed at 7 d.p.i., and all tissues were 
Salmonella positive in both Ad5-G-CSF-treated and Ad5-empty-
treated pigs. Of these three tissues, the Peyer’s patch region of 
the ileum exhibited a significant 0.5-log reduction in Salmonella 
colonization in the Ad5-G-CSF-treated pigs compared to the 
Ad5-empty-treated group (Figure  3A). A striking difference 
in tonsil colonization was observed between treatment groups 
(Figure 3B). Eight of the nine Ad5-G-CSF-treated pigs harbored 
no detectable Salmonella in the tonsil, with only one pig being 
qualitatively positive for Salmonella in the tonsils (i.e., by enrich-
ment). By contrast, all seven Ad5-empty-treated pigs harbored 
Salmonella in the tonsils at an average of ~10,000 CFU/g. These 
data suggest that prophylactic administration of Ad5-G-CSF can 
reduce Salmonella colonization and subsequent fecal shedding, 
including the tonsils that have been implicated in the carrier-
status of Salmonella (28–31).
The gastrointestinal Microbiota of 
Salmonella-challenged Pigs Was More 
stable in the ad5-g-csF-Treated Pigs
Fecal 16S rRNA gene sequence data were used to compare the 
gastrointestinal bacterial communities of the Ad5-G-CSF and 
Ad5-empty treatment groups following Salmonella challenge. 
No significant differences in indices for diversity, evenness, or 
richness were detected among treatments or timepoints. OTU-
based analysis of bacterial community structure showed that at 
FigUre 3 | Tissue colonization from Salmonella-challenged pigs, with 
or without prior ad5-g-csF administration. At 7 d.p.i., Salmonella 
bacteriological analysis (CFU/g) of the (a) Peyer’s patch region of the ileum 
and (B) tonsils obtained during necropsy. *Significant difference (P < 0.05) 
comparing Ad5-G-CSF-treated to Ad5-empty-treated pigs at the same time 
point.
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7 days post-Salmonella challenge, the microbiota of pigs that had 
received Ad5-G-CSF was not significantly different from that of 
day 2 or 3 (ANOSIM, p > 0.05; R < 0.1), but the microbiota of 
pigs that received Ad5-empty treatment was significantly differ-
ent at day 7 compared to all previous time points (ANOSIM, 
p < 0.05; R > 0.25). However, the difference between the Ad5-
G-CSF-treated and Ad5-empty-treated groups at day 7 was 
insignificant. The dissimilarity of the microbiotas between days 
3 and 7 was visualized via an NMDS plot, which showed the 
disturbed microbiota at day 7 in the Ad5-empty-treated animals 
compared to Ad5-G-CSF-treated animals (Figure 4). These results 
demonstrate that Ad5-G-CSF administration slightly decreases 
the beta-diversity changes in the microbiota that are caused by 
Salmonella challenge, suggesting that Ad5-G-CSF mitigated the 
disturbance to the gut microbiota that was caused by Salmonella.
DiscUssiOn
Granulocyte-colony stimulating factor is a cytokine that influ-
ences the proliferation, differentiation, maturation, function, and 
survival of neutrophils (32). Neutrophils are a critical mediator 
of antimicrobial defense during the initial stages of infection and 
have effects on a number of microbial targets (8). Circulating 
neutrophil numbers in swine have been correlated with resistance 
to salmonellosis, with pigs most resistant to Salmonella exhibiting 
higher numbers of circulating neutrophils and enhanced neutro-
phil function (19). In the current study, treatment of swine with 
Ad5-G-CSF increased the number of circulating neutrophils by 
10-fold, decreased Salmonella-induced disturbance of the gastro-
intestinal microbiota, and reduced Salmonella fecal shedding 1–2 
logs during the acute stage of infection. Thus, prophylactic use 
of G-CSF as an immunostimulant may be an effective strategy 
to reduce Salmonella in swine herds. A farm-to-consumption 
quantitative microbiological risk assessment (QMRA) for 
Salmonella in pigs in the European Union concluded that inter-
ventions should focus on decreasing the level of Salmonella in 
the feces of infected swine because the vast majority of human 
risk is derived from a subset of pigs with a high concentration 
of Salmonella in their feces (≥104 CFU/g) (33). In our study, the 
Ad5-empty-treated pigs shed Salmonella at 104–5  CFU/g, and 
Ad5-G-CSF treatment reduced the level of Salmonella fecal shed-
ding to 103 CFU/g, further supporting G-CSF administration as 
a possible risk mitigation strategy.
The dramatic reduction in Salmonella colonization of the 
tonsils in the Ad5-G-CSF-treated pigs also highlights prophy-
lactic treatment with G-CSF as a potential control strategy for 
persistently infected pigs. Salmonella can reside in lymph nodes 
and especially the tonsils (28–31). In this carrier-state, a stressful 
event (farrowing, weaning, or transport) can trigger Salmonella 
to re-emerge and reseed the gastrointestinal tract, resulting in 
shedding recrudescence (34, 35). Reduction of tonsil coloniza-
tion, as observed in the Ad5-G-CSF-treated pigs, may reduce the 
reseeding process during stress. An intriguing follow-up study 
would be to evaluate the recrudescence of Salmonella in colo-
nized pigs that are given Ad5-G-CSF prior to an applied stress 
(mixing, transportation, etc.). While additional investigations 
of the efficacy and safety of Ad5-G-CSF administration in swine 
are warranted, our data suggest that increasing the number of 
circulating neutrophils via Ad5-G-CSF administration may 
offer a non-specific yet effective method for reducing Salmonella 
colonization in swine.
Inflammation-associated intestinal dysbiosis can result 
in pathogen expansion, especially for microorganisms, such 
as Salmonella, that are capable of taking advantage of an 
inflamed environment (36). We have previously shown that 
Salmonella colonization of the porcine gastrointestinal tract 
causes a disturbance within the gut microbial community (37) 
and triggers an inflammatory response from the host (17, 18). 
Intervention strategies that target Salmonella during the initial 
stages of colonization could reduce overall gut inflammation 
and subsequently prevent the development of a “nutrient-niche” 
that can be selectively used by Salmonella (38). In the current 
study, prophylactic Ad5-G-CSF administration was beneficial 
in reducing the Salmonella-induced microbiota disturbance. 
Nevertheless, neutrophils are a primary player in the inflam-
matory response, and their contribution to the inflammatory 
response that provides an optimal environment for Salmonella 
expansion needs to be considered with an intervention strategy 
that increases neutrophils in circulation. It may be important 
to establish an optimal neutrophilia for the greatest Salmonella 
reduction with minimal neutrophil-stimulated tissue damage 
FigUre 4 | non-metric multidimensional scaling (nMDs) analyses of 16s rrna gene OTUs from Salmonella-challenged pigs with prior 
administration of ad5-empty (a) or ad5-g-csF (B). Shown are the fecal microbiotas from samples taken at 3 days [(a), green; (B), orange] and 7 days 
[(a), blue; (B), red] post-Salmonella challenge. OTU cutoff of 97% similarity was used. Stress = (a), 0.1445; (B), 0.1453.
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that, in itself, could encourage S. Typhimurium virulence factor-
induced inflammation (36).
As regulatory and public scrutiny necessitates the judicious 
use of antibiotics in food animals (39, 40), the need for antibiotic 
alternatives in animal production intensifies. Naturally occurring 
biotherapeutics engineered for pharmaceutical application offer 
an alternative to antibiotic usage, especially for prophylactic 
or possibly metaphylactic administration during periods of 
anticipated stress and host susceptibility. Through the general 
activation of innate immune defenses, immunostimulants may 
provide effective pathogen reduction or elimination with broad 
application against bacteria and viruses that pose a food safety 
threat or that negatively impact animal health. Our results sug-
gest that prophylactic use of Ad5-G-CSF in swine could decrease 
subclinical or clinical disease by microorganisms that are targeted 
by neutrophils.
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